MedTrace Logo

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

NCT04556019 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-09-21

No results posted yet for this study

Summary

The main aims of this study are:

1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit.
2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.

Conditions

  • Pancreas Disease
  • Liver Diseases
  • Surgical Procedure, Unspecified
  • Bile Duct Diseases

Interventions

PROCEDURE

Hepatobiliopancreatic surgery

Different surgical techniques tailored to each patient´s pathology

Sponsors & Collaborators

  • Fundacion Miguel Servet

    lead OTHER

Principal Investigators

  • Francisco Javier Herrera Cabezón, MD · Complejo Hospitalario de Navarra

Eligibility

Min Age
15 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2024-01-31
Completion
2029-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04556019 on ClinicalTrials.gov